Cite
Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials.
MLA
Mehrotra, Devan V., et al. “Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials.” Annals of Internal Medicine, vol. 174, no. 2, Feb. 2021, pp. 221–28. EBSCOhost, https://doi.org/10.7326/M20-6169.
APA
Mehrotra, D. V., Janes, H. E., Fleming, T. R., Annunziato, P. W., Neuzil, K. M., Carpp, L. N., Benkeser, D., Brown, E. R., Carone, M., Cho, I., Donnell, D., Fay, M. P., Fong, Y., Han, S., Hirsch, I., Huang, Y., Huang, Y., Hyrien, O., Juraska, M., & Luedtke, A. (2021). Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials. Annals of Internal Medicine, 174(2), 221–228. https://doi.org/10.7326/M20-6169
Chicago
Mehrotra, Devan V., Holly E. Janes, Thomas R. Fleming, Paula W. Annunziato, Kathleen M. Neuzil, Lindsay N. Carpp, David Benkeser, et al. 2021. “Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials.” Annals of Internal Medicine 174 (2): 221–28. doi:10.7326/M20-6169.